Genetesis: A medical imaging company bridging state of the art data science and biomagnetism to win the fight against cardiovascular disease
Genetesis is innovating the diagnostic cardiac space with a new scanning method as benign and painless as ECG, but with accuracy only otherwise available through intrusive, sometimes painful, and radiative triage measures. Genetesis and their novel CardioFlux scanning procedure is working to save the 8 million patients per year that come in for cardiac concerns in the US and do so with a 90 second painless scan that leverages proprietary geometric scan design and the latest in data science and analysis.
"TDK’s rich history in magnetics and its recent breakthroughs in biomagnetics at picoTesla levels makes them one of our strongest partners to date. We are committed to bring the most accurate diagnostics that can assist emergency physicians and cardiologists in making the best decisions for cardiac health in a non-invasive and a rapid fashion. We are elated to have TDK as our strategic partner because of their pioneering work in magnetic materials and its commercialization. Their recent leadership around supporting frontier-tech entrepreneurs caught our attention and we are excited about this next chapter."